摘要
随着胰高血糖素样肽-1（GLP-1）受体激动剂的广泛应用，越来越多的研究表明，此类药物能够通过调节血糖、血脂、血压，并通过抗炎、抗氧化应激等机制，发挥保护心肌、改善心肌梗死和心力衰竭等方面的效应。
Along with the wide use of glucagon-like peptide-1 （ GLP-1 ） receptor agonists, evidence has been accumulated that GLP-1 receptor agonists could lead to myocardial protection, improvement of myo- cardial infarction and heart failure by ways of regulating blood glucose, lipid and blood pressure, anti-inflam-mation and anti-oxidative stress, etc.
出处
《国际内分泌代谢杂志》
北大核心
2012年第4期242-244,共3页
International Journal of Endocrinology and Metabolism
关键词
胰高血糖素样肽-1
炎症
氧化应激
心肌梗死
心力衰竭
Glucagon-like peptide-1
Inflammation
Oxidative stress
Myocardial infarction
Heart failure
